When meeting increased demand of a key raw material used in a commercial immunoassay, we work both, upstream and downstream, to optimize and scale-up the manufacturing process.

Watch this content to learn more about a scale-up project, in which thanks to the joint effort between R&D and manufacturing, we were able to increase the production 10-fold in a timely manner, while avoiding a regulatory impact as the final performance and specifications of the biomaterial remained the same.